Search Results - "Charitou, Vicky"

Cyclization and Docking Protocol for Cyclic Peptide–Protein Modeling Using HADDOCK2.4 by Charitou, Vicky, van Keulen, Siri C., Bonvin, Alexandre M. J. J.

“…An emerging class of therapeutic molecules are cyclic peptides with over 40 cyclic peptide drugs currently in clinical use. Their mode of action is, however,…”
Get full text

Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles by Habjan, Eva, Lepioshkin, Alexander, Charitou, Vicky, Egorova, Anna, Kazakova, Elena, Ho, Vien QT, Bitter, Wilbert, Makarov, Vadim, Speer, Alexander

“…Developing effective tuberculosis drugs is hindered by mycobacteria's intrinsic antibiotic resistance because of their impermeable cell envelope. Using…”
Get full text

Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism by Jekhmane, Shehrazade, Derks, Maik G. N., Maity, Sourav, Slingerland, Cornelis J., Tehrani, Kamaleddin H. M. E., Medeiros-Silva, João, Charitou, Vicky, Ammerlaan, Danique, Fetz, Céline, Consoli, Naomi A., Cochrane, Rachel V. K., Matheson, Eilidh J., van der Weijde, Mick, Elenbaas, Barend O. W., Lavore, Francesca, Cox, Ruud, Lorent, Joseph H., Baldus, Marc, Künzler, Markus, Lelli, Moreno, Cochrane, Stephen A., Martin, Nathaniel I., Roos, Wouter H., Breukink, Eefjan, Weingarth, Markus

“…Antimicrobial resistance is a leading cause of mortality, calling for the development of new antibiotics. The fungal antibiotic plectasin is a eukaryotic host…”
Get full text